Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine.

The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

She breastfed her little one for just over a year, and with all the new changes in her life, she was too busy to gain weight.Also read: Study links weight loss drug to rare eye conditionIn Europe, she ...

When the stock market experiences a sharp decline, as it did after the Trump administration announced tariffs on its trade partners and China responded with retaliatory tariffs, many investors start ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...